IPUBLIC RECORDSEXCHANGERECEIPTSloadinglive·IMONEY TRAILEXCHANGESOURCESverifyinglive·IDATA SOURCESEXCHANGEFILINGSpublic recordslive·IPUBLIC RECORDSEXCHANGERECEIPTSloadinglive·IMONEY TRAILEXCHANGESOURCESverifyinglive·IDATA SOURCESEXCHANGEFILINGSpublic recordslive·
← Today’s Receipts
Public-record receiptD-ILSource pending

Jonathan Jackson disclosed BUY $LLY

Here’s the public record: who traded, what they disclosed, when it happened, how late it appeared, and what context is attached.

Trade range
$1K – $15K
Filed
2025-08-26
Trade date
2025-04-23
Disclosure lag
125 days after trade

Why this receipt matters

A quick read before you share it.

These are factual context points from the receipt and linked public-record data. They explain why the disclosure may be worth opening, not whether anyone acted improperly.

Source pending
1The disclosure is tracked with source status pending, so treat it as a record to verify rather than a finished source trail.
2The filing appeared 125 days after the trade date, beyond the standard 45-day STOCK Act window.
3The disclosed range is $1K – $15K, which is the public reporting band rather than an exact profit or loss figure.
426 nearby same-ticker disclosures appeared in the surrounding 30-day window.
5Committee context is available for Jonathan Jackson, but PoliWealth treats it as context - not proof of intent or wrongdoing.
6Related public-record context includes 33 lobbying filings.

Source

source pending
Source: indexed congressional disclosure; official source link pending · filed 2025-08-26 · disclosed 125d after transaction

Market context

Eli Lilly and Company

Sector: Healthcare

Factual flags

  • Filed after the standard 45-day STOCK Act window.
  • 33 lobbying filings linked to this ticker.
  • 26 nearby same-ticker disclosures in the surrounding 30-day window.
  • 12 trades filed on 2025-08-26 (batch dump)
  • Filed 125 days after transaction (STOCK Act limit: 45)

Member trail

Jonathan Jackson

U.S. House · IL-1

House Committee on AgricultureHouse Committee on Foreign Affairs

Ticker trail

$LLY

Eli Lilly and Company

Follow this ticker

Alert me when this ticker gets a new congressional receipt. This page reports public disclosures and factual context only. It does not determine intent, is not an accusation, and is not investment advice.